002513SZSE

Lanfeng Biochemical Co., Ltd.

蓝丰生化

002513

Shenzhen Stock Exchange

Follow
30 announcements tracked· Last: May 12, 2026

Key Financials

Revenue¥652.1M
Net Profit-¥14.8M
ROE-37.02%
Debt Ratio91.43%
Monetary Funds¥618.0M
Receivables¥693.5M
Total Shares375.6M

Announcements

30 total

Announcement on the Expiration of the Share Reduction Plan Period for Company Shareholders and Implementation Results

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Legal Opinion from Beijing Wanshang Tianqin Law Firm Regarding the 2025 Annual Shareholders' Meeting of Jiangsu Lanfeng Biochemical Co., Ltd.

Share PledgeShareholding Change DisclosureListed Company Announcements

Announcement of the 2025 Annual Shareholders' Meeting Resolutions

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement of the 34th Meeting Resolution of the 7th Board of Directors

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Q1 2026 Report

Share Repurchase CompletionShareholding Change DisclosurePeriodic Financial Reports

Announcement on Holding the 2025 Online Performance Briefing

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Progress Announcement on Providing Guarantees for Holding Subsidiaries

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Renewal of the Company's Audit Institution for 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Confirmation of 2025 Annual Remuneration for Directors and Senior Management and the 2026 Remuneration Plan

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Yuan Jian)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Tang Jian)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Independent Director Work Report (Liu Xingchong)

Convertible BondsShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Audit Report

Share PledgeShareholding Change DisclosureListed Company Announcements

2025 Annual Internal Control Self-evaluation Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Articles of Association of Jiangsu Lanfeng Biochemical Co., Ltd. (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Remuneration Management System for Directors and Senior Management (April 2026)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Increasing Registered Capital, Amending the Articles of Association, and Handling Business Registration and Revising Corporate Governance Systems

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on Changes in Accounting Policies

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Company's Uncovered Losses Reaching One-third of the Total Paid-in Capital

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Increase of Borrowing Limit from Controlling Shareholders by the Company and its Controlling Subsidiaries and Related Transactions

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Application for Comprehensive Credit Limits from Financial Institutions by the Company and Subsidiaries in 2026 and Acceptance of Related Party Guarantees

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Expected Financial Assistance Limit for Subsidiaries and Related Transactions in 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Feasibility Analysis Report on Conducting Derivative Trading Business in 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Announcement on the Expected Derivative Trading Limit for 2026

Share Repurchase PlanShareholding Change DisclosureListed Company Announcements

Announcement on the Expected External Guarantee Limit for Subsidiaries in 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notice of the 2025 Annual Shareholders' Meeting

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Resolution of the First Special Meeting of Independent Directors in 2026

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Shareholder Return Plan for the Next Three Years (2026-2028)

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Financial Settlement Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

2025 Annual Board Work Report

Share Repurchase CompletionShareholding Change DisclosureListed Company Announcements

Notes & Comments

Sign in to leave a comment or private note.

Loading…